Alzheimer's disease – Newseum Global

Alzheimer’s drug Leqembi promises to give patients more time, but they face a long road to treatment

Hannah Yoon | The Washington Post | Getty Images Leqembi, an Alzheimer’s drug from Biogen and…

GE Healthcare on Wednesday morning reported a mixed second quarter and shares initially moved sharply lower.…

The Alzheimer’s drug Leqembi is seen in this undated handout image obtained by Reuters on January…

The Food and Drug Administration on Thursday fully approved the Alzheimer’s treatment Leqembi, a pivotal decision…

Jay Reinstein, who suffers from Alzheimer’s, receives an injection so he can have a PET scan…